SCHEMBL25016710

SCHEMBL25016710

CC(C)c1cccc(C2CCC(O)C2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOS1 Q07889 1/20 0.40
▸ ADAM10 O14672 3/20 0.39
▸ ERBB2 P04626 1/20 0.39
▸ MMP2 P08253 1/20 0.38
▸ MGLL Q99685 5/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MDM4 O15151 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ TYR P14679 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ CA5A P35218 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ HDAC4 P56524 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15566600 0.84 HTR2C (0.43) SOS1ADAM10ERBB2MMP2MGLL
SCHEMBL6388862 0.78 ESR2 (0.43) SOS1ADAM10ERBB2MMP2MGLL
SCHEMBL7634263 0.78 HDAC4 (0.47) ADAM10ERBB2MMP2KDM4EMDM4
SCHEMBL5667630 0.76 KMO (0.49) ADAM10ERBB2MMP2KDM4EMDM4
SCHEMBL15502380 0.75 QDPR (0.50) ADAM10ERBB2MMP2DRD2DRD3
SCHEMBL26816768 0.75 NOTUM (0.43) SOS1ADAM10ERBB2MMP2MGLL
SCHEMBL27969280 0.75 F2R (0.38) ADAM10ERBB2MMP2MGLLHDAC4
SCHEMBL23380258 0.75 NOTUM (0.52) SOS1ADAM10ERBB2MMP2MGLL
SCHEMBL23363533 0.75 KDM1A (0.49) HDAC4DRD2DRD3
SCHEMBL9196045 0.75 TRPV1 (0.47) HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 SOS1 3426/4885ADAM10 25/4885ERBB2 1146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback